Cirrhotic (n=49)

Non-cirrhotic (n=37)

Age¹

 64.02(12.56)

60.32 (17.97)

Male gender²

35(71.42%)

 25 (68.62%)

Clinical features²

Ecografical surveillance

19(36.8%)

1 (2.70%)

Incidental findingٰ

19(23%)

12(32.43%)

nonspecific symptoms

 5(29.9%)

20(54.05%)

Othersٰ

 6(6.9%)

4(10.81%)

Radiological findings

Largest tumor size (mm)³

  68.26(41.41)

101(43.52)

Total tumor size (mm)³

   79.91(45.10)

 116.05(65.37)

Number of nodules¹

1.95(1-10)

 1.24 (0.49)

Macroscopical invasion²

8(16.32%)

9(24.32%)

Preoperatory AFP (ng/dl)ٰ¹

805.96(1,5-80.000)

 3572.32

Preoperatory portal embolization²

11(20,2%)

6(16,21%)

Neoadjuvant therapy²

12(24,48%)

2(5,40%)

Within Milán²

19(38.78%)

5(13.51%)

Within UCSF²

23(46.94%)

8(21.62%)

Specimen findings

Largest tumor size (mm)³

 59.38(35.23)

 97.56(52.78)

Number of nodules¹

1.69(1-10)

1.37(1-3)

Lymphovascular invasion²

25(51.02 %)

  19(51.35%)

Edmondson-Steinerٰ²

Grade II

6(12.24%)

  3(8.11%)

Grade II

20(40.82%)

12(32.43%)

Grade III

14(28.57%)

18(48.65%)

Grade IV

 9(18.37%)

  4(10.81%) 

surgical margins¹

1 (2.04%)

3 (8.33%)

1= [mean (standard deviation)],  2= n (%)

3= [mean (range)],

[ n (%)]